HIGHLIGHTS
- who: Yongzhuo Yu from the University of Zurich, Switzerland have published the Article: Circadian rhythm of plasminogen activator inhibitor-1 and cardiovascular complications in type 2 diabetes, in the Journal: (JOURNAL)
- future: Studies are needed to clarify it.
SUMMARY
Frontiers in Endocrinology frontiersin.org 10.3389/fendo.2023.1124353 diabetic cardiovascular complications, the authors summarized the possibility of using the circadian rhythm of PAI-1 to treat the cardiovascular complications of diabetes using "chronotherapy". Plasminogen-activator Inhibitor 1 (PAI-1) participates in the occurrence and development of this state and is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.